Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025;1(1):9.
doi: 10.1038/s44400-025-00012-4. Epub 2025 Jun 3.

Non-coding variation in dementias: mechanisms, insights, and challenges

Brianne B Rogers  1 , J Nicholas Cochran  1
Affiliations
Review

Non-coding variation in dementias: mechanisms, insights, and challenges

Brianne B Rogers et al. NPJ Dement. 2025.

Abstract

Dementia encompasses many neurodegenerative disorders. While some causal coding variants are known, most GWAS variants are in non-coding regions of the genome, making understanding functional impacts challenging. This review explores the role of non-coding variation in dementia, covering methods to identify enhancers and their target genes, prioritize GWAS variants, and validate the functional effects of variation, providing a comprehensive framework for investigating non-coding variation and its implications in dementia research.

Keywords: Dementia; Genetics; Neurodegeneration; Neurodegenerative diseases.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Regulation of gene expression mediated by enhancers.
Illustration of chromosomal looping, mediated by CTCF and cohesin, that allows a distal enhancer to be in close proximity and interact with the promoter of its target gene. These interactions increase binding of transcription factors, chromatin remodelers, and the Mediator complex to recruit RNA polymerase II (RNAPII) at the promoter of the target gene. Active promoters and enhancers are in regions of open chromatin, depleted of nucleosomes. Active enhancers are flanked by nucleosomes with specific histone modifications (H3K4Me1 and H3K27Ac).
See this image and copyright information in PMC

References

    1. World Health Organization. Fact sheets of dementia. https://www.who.int/news-room/fact-sheets/detail/dementia (2023).
    1. Alzheimer’s Association. 2024 Alzheimer’s disease facts and figures. Alzheimers Dement.20, 3708–3821 (2024). - PMC - PubMed
    1. Stelzmann, R. A., Norman Schnitzlein, H. & Reed Murtagh, F. An english translation of alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde”. Clin. Anat.8, 429–431 (1995). - PubMed
    1. Braak, H., Thal, D. R., Ghebremedhin, E. & Tredici, K. D. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 Years. J. Neuropathol. Exp. Neurol. 70, 960–969 (2011). - PubMed
    1. Golde, T. E. Alzheimer’s disease – the journey of a healthy brain into organ failure. Mol. Neurodegener.17, 1–19 (2022). - PMC - PubMed